GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Vita 34 AG (XTER:V3V) » Definitions » Cyclically Adjusted Revenue per Share

Vita 34 AG (XTER:V3V) Cyclically Adjusted Revenue per Share : €5.67 (As of Sep. 2023)


View and export this data going back to 2007. Start your Free Trial

What is Vita 34 AG Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Vita 34 AG's adjusted revenue per share for the three months ended in Sep. 2023 was €1.262. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is €5.67 for the trailing ten years ended in Sep. 2023.

During the past 12 months, Vita 34 AG's average Cyclically Adjusted Revenue Growth Rate was 2.30% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 0.20% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was -0.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Vita 34 AG was 0.20% per year. The lowest was -1.80% per year. And the median was -1.60% per year.

As of today (2024-05-24), Vita 34 AG's current stock price is €4.66. Vita 34 AG's Cyclically Adjusted Revenue per Share for the quarter that ended in Sep. 2023 was €5.67. Vita 34 AG's Cyclically Adjusted PS Ratio of today is 0.82.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Vita 34 AG was 3.23. The lowest was 0.71. And the median was 2.28.


Vita 34 AG Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Vita 34 AG's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vita 34 AG Cyclically Adjusted Revenue per Share Chart

Vita 34 AG Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.53 5.46 5.23 5.27 5.50

Vita 34 AG Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.54 5.50 5.62 5.63 5.67

Competitive Comparison of Vita 34 AG's Cyclically Adjusted Revenue per Share

For the Medical Care Facilities subindustry, Vita 34 AG's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vita 34 AG's Cyclically Adjusted PS Ratio Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Vita 34 AG's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Vita 34 AG's Cyclically Adjusted PS Ratio falls into.



Vita 34 AG Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Vita 34 AG's adjusted Revenue per Share data for the three months ended in Sep. 2023 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Sep. 2023 (Change)*Current CPI (Sep. 2023)
=1.262/124.1946*124.1946
=1.262

Current CPI (Sep. 2023) = 124.1946.

Vita 34 AG Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201312 1.171 99.356 1.464
201403 1.032 99.543 1.288
201406 0.924 99.543 1.153
201409 1.280 99.823 1.593
201412 1.186 99.543 1.480
201503 1.041 99.717 1.297
201506 0.979 100.417 1.211
201509 1.245 100.417 1.540
201512 1.374 99.717 1.711
201603 1.250 100.017 1.552
201606 1.498 100.717 1.847
201609 1.360 101.017 1.672
201612 1.192 101.217 1.463
201703 1.432 101.417 1.754
201706 1.354 102.117 1.647
201709 1.816 102.717 2.196
201712 1.073 102.617 1.299
201803 1.150 102.917 1.388
201806 1.291 104.017 1.541
201809 1.272 104.718 1.509
201812 1.161 104.217 1.384
201903 1.134 104.217 1.351
201906 1.190 105.718 1.398
201909 1.313 106.018 1.538
201912 1.129 105.818 1.325
202003 1.178 105.718 1.384
202006 1.182 106.618 1.377
202009 1.303 105.818 1.529
202012 1.164 105.518 1.370
202103 1.224 107.518 1.414
202106 1.462 108.486 1.674
202109 1.402 109.435 1.591
202112 0.778 110.384 0.875
202203 0.992 113.968 1.081
202206 1.056 115.760 1.133
202209 0.967 118.818 1.011
202212 1.103 119.345 1.148
202303 1.116 122.402 1.132
202306 1.078 123.140 1.087
202309 1.262 124.195 1.262

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Vita 34 AG  (XTER:V3V) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Vita 34 AG's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=4.66/5.67
=0.82

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Vita 34 AG was 3.23. The lowest was 0.71. And the median was 2.28.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Vita 34 AG Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Vita 34 AG's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Vita 34 AG (XTER:V3V) Business Description

Industry
Traded in Other Exchanges
Address
Deutscher Platz 5a, Leipzig, DEU, D-04103
Vita 34 AG is an umbilical cord blood bank. It supplies cryo-preservation and provides for the logistics to collect the blood, the preparation and the storage of stem cells from umbilical cord blood and tissue. The Group has two strategic areas that constitute the Group's reportable segments. Both segments are active in the field of stem cell banking, but differ in their organizational and operational structure with separate financial information. The products and services of the two segments correspond to the service portfolios of the two subgroups PBKM and Vita 34. It operates in Germany, Spain, and other international countries, of which maximum revenue is derived from the business operations in Germany.
Executives
Jakub Julian Baran Member of the Management Board
Dr. Alexander Granderath Supervisory Board

Vita 34 AG (XTER:V3V) Headlines

No Headlines